These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 979066)

  • 21. [The influence of saralasine on blood pressure and renal function in Bartter's syndrome and decompensated hepatic cirrhosis (author's transl)].
    Klaus D; Witzgall H; Zehner J; Dürr H; Lange H
    Dtsch Med Wochenschr; 1976 Sep; 101(37):1357-9. PubMed ID: 954592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the angiotensin II antagonist 1-sar-8-ala-angiotensin II in hypertension in man.
    Fagard R; Amery A; Lijnen P; Reybrouck T
    Eur J Clin Invest; 1977 Dec; 7(6):473-9. PubMed ID: 415868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The changes in renin-angiotensin-aldosterone-system in different subtypes of Cushing's syndrome].
    Cui J; Dou J; Yang G; Zang L; Jin N; Chen K; Du J; Gu W; Wang X; Yang L; Lyu Z; Ba J; Mu Y; Lu J; Li J; Pan C
    Zhonghua Nei Ke Za Zhi; 2015 Jul; 54(7):618-22. PubMed ID: 26359025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the effect of angiotensin II and of Des -angiotensin II on blood pressure, plasma renin activity and plasma aldosterone in the dog.
    Beckerhoff R; Uhlschmid G; Vetter W; Siegenthaler W
    Clin Sci Mol Med Suppl; 1976 Dec; 3():147s-150s. PubMed ID: 1071593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD; Tucker R; Tue K; Wisgerhof M; Salassa R
    J Lab Clin Med; 1978 Mar; 91(3):473-9. PubMed ID: 627750
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin II blockade in patients with essential hypertension.
    MacGregor GA; Dawes PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):53-4. PubMed ID: 1071404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two angiotensin II analogues on blood pressure, plasma aldosterone concentration, plasma renin activity and creatinine clearance in normal subjects on different sodium intakes.
    Hata T; Ogihara T; Mikami H; Nakamaru M; Mandai T; Kumahara Y
    Eur J Clin Pharmacol; 1980 Oct; 18(4):295-9. PubMed ID: 7002566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ; Boyd GW; Peart WS
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of angiotensin II and of an angiotensin II analogue (Sar1-Ile8-angiotensin II) on blood pressure, plasma aldosterone and plasma renin activity in the dog.
    Beckerhoff R; Uhlschmid G; Vetter W; Armbruster H; Nussberger J; Reck G; Schmied U; Siegenthaler W
    Clin Sci Mol Med Suppl; 1975 Jun; 2():41s-44s. PubMed ID: 1077788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The renin-angiotensin-aldosterone system in patients with nephrotic syndrome: effects of 1-sar-8-ala-angiotensin II.
    Düsing R; Vetter H; Kramer HJ
    Nephron; 1980; 25(4):187-92. PubMed ID: 6990285
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
    Saruta T; Suzuki H; Handa M; Igarashi Y; Kondo K; Senba S
    J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of sar1 ala8 angiotensin II (saralasin) on plasma aldosterone in hypertensive patients.
    Donker AJ; van Hoogdalem P; Pratt JJ; Leenen FH
    Acta Med Scand; 1979; 205(3):207-12. PubMed ID: 425848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension.
    Kreft C; Menard J; Corvol P
    Kidney Int; 1979 Feb; 15(2):176-83. PubMed ID: 513483
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of angiotensin II antagonist to blood pressure, plasma renin activity and plasma aldosterone concentration in chronic renal failure (author's transl)].
    Nigawara K; Yagihashi Y; Kogawa T; Kawamata A; Yamaya K; Sugawara S; Tulachan Y; Funyu T; Eba H; Kido K; Tanaka T; Morita S; Fukushi M; Furusawa M; Terayama Y; Hirayama N
    Nihon Jinzo Gakkai Shi; 1979 Nov; 21(11):1231-42. PubMed ID: 396404
    [No Abstract]   [Full Text] [Related]  

  • 35. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cushing's disease: evaluation of mineralocorticoid-induced hypertension.
    Yasuda G; Shionoiri H; Hayashi S; Umemura S; Ikeda Y; Ishii M
    Intern Med; 1993 Oct; 32(10):784-8. PubMed ID: 8012073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Lancet; 1975 Oct; 2(7939):784-7. PubMed ID: 78152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic and pharmacodynamic studies of infusions with [Sar 1, Val5, Ala8] angiotensin II (saralasin).
    Gless KH; Bönner G; Gram N; Mann JF; Helber A; Ganten D
    Klin Wochenschr; 1978; 56 Suppl 1():97-105. PubMed ID: 732257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of angiotensin II blockade by saralasin in normal man.
    Noth RH; Tan SY; Mulrow PJ
    J Clin Endocrinol Metab; 1977 Jul; 45(1):10-5. PubMed ID: 874056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J; Liebau G; Steiner B; Schick K; Hayduk K
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():212-3. PubMed ID: 613577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.